Angiotensin Receptor-Neprilysin Inhibition (ARNI) Therapy and Reverse Remodeling in Heart Failure with Reduced Ejection Fraction

Research output: Contribution to journalEditorial

Fingerprint Dive into the research topics of 'Angiotensin Receptor-Neprilysin Inhibition (ARNI) Therapy and Reverse Remodeling in Heart Failure with Reduced Ejection Fraction'. Together they form a unique fingerprint.